Comparative responsiveness of short-form 12 and Minnesota living with heart failure questionnaire in patients with heart failure

Journal of Cardiac Failure

Volumn 6, Issue 2, 2000, Pages 83-91

  Ni, Hanyu ^a   Toy, Warren ^a   Burgess, Donna ^a   Wise, Kendra ^a   Nauman, Deirdre J ^a   Crispell, Kathy ^a   Hershberger, Ray E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Heart failure; Quality of life; Responsiveness

Indexed keywords

ARTICLE; HEALTH STATUS; HEART FAILURE; HUMAN; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0033922373     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2000.7869     Document Type: Article

References (27)

1. Bonow R, Udelson J: Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992:502-10
2. Guyatt G: Measurement of health-related quality of life in heart failure. J Am Coll Cadiol 1993;22:185A-91A (suppl A)
3. Rector T, Kubo S, Cohn J: Patients' self-assessment of their congestive heart failure: II. Content, reliability and validity of a new measure - the Minnesota Living With Heart Failure Questionnaire. Heart Fail 1987;3:198-209
4. Ware J, Kosinski M, Keller S: A 12-item short form health survey construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33
5. Ware J, Sherbourne C: The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
6. Kubo S, Gollub S, Bourge R: Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Circulation 1992;85:942-9
7. Rector T, Cohn J: Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992; 124:1017-25
8. Rector T, Kubo S, Cohn J: Validity of the Minnesota Living With Heart Failure Questionnaire as a measure of therapeutic response: effects of enalapril and placebo. Am J Cardiol 1993;71:106-7
9. Jenkinson C, Layte R, Jenkinson D, Lawrence K, Petersen S, Paice C, Stradling J: A shorter form health survey: Can the SF-12 replicate results from the SF-36 in longitudinal studies? J Public Health Med 1997;19:179-86
10. Rich M, Beckham V, Wittenberg C, Leven C, Freedland K, Carney R: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5
11. Fonarow G, Stevenson L, Walden J, Livingston NA, Steimle AE, Hamilton MA, Moriguchi J, Tillisch JH, Woo MA: Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-32
12. West J, Miller N, Parke K, Senneca D, Ghandour G, Clark M, Greenwald G, Heller RS, Fowler MB, DeBusk RF: A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997;79:58-63
13. Hanumanthu S, Butler J, Chomsky D, Davis S, Wilson J: Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 1997;96:2842-8
14. Binman A, Keane D, Lurie N: Measuring health changes among severely ill patients. Med Care 1990;28:1142-52
15. Ware J, Kosinski M, Keller S: SF-12: how to score the SF-12 physical and mental health summary scales (ed 2). New England Medical Center, Boston, MA, The Health Institute, 1995
16. Fortin P, Stucki G, Katz J: Measuring relevant change: an emerging challenge in rheumatologic clinical trials. Arthritis Rheum 1995;38:1027-30
17. Liang M, Fossel A, Larson M: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-42
18. Kleinbaum D, Kupper L, Muller K: The correlation coefficient and straight-line regression analysis. In Payne M (ed): Applied regression analysis and other multivariate methods, vol. 80. Belmont, CA, Wardsworth, 1988, pp 80-93
19. Stucki G, Liang M, Fossel A, Katz J: Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 1994;48:1369-78
20. Deyo R, Diehr P, Patrick D: Reproducibility and responsiveness of health status measures. Statistical and strategies for evaluation. Control Clin Trials 1991;12:142S-58S
21. Cohen J: Statistical power analyses for the behavioral sciences. New York, NY, Academic Press, 1977
22. Simon G, Revicki D, Grothaus L, Vonkorff M: SF-36 summary score. Are physical and mental health truly distinct? Med Care 1998;36:567-72
23. Rector T, Johnson G, Dunkman B, Daniels G, Farrell L, Henrick A, Smith B, Conn JN: Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life: V-HeFT II. Circulation 1993;87:VI71-7 (suppl VI)
24. Packer M, Colucci W, Sackner-Bernstein J, Liang CE, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb S, Pearl D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young St, Lukas MA, Shusterman NH: Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE trial. Circulation 1996;94:2793-9
25. Rector T: Measurement of clinical efficacy in studies of heart failure. Circulation 1998;97:707
26. Cowley A, Stainer K, Wynne R, Rowley J, Hampton J: Symptomatic assessment of patients with heart failure: Double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Lancet 1986;2:770-2
27. Contadson T, Ryden L, Ahlmark G: Clinical efficacy of hydralazine in chronic heart failure: One-year double-blind placebo-controlled study. Am Heart J 1984; 108:1001-6